94 related articles for article (PubMed ID: 6366672)
1. [Diagnosis of acute myelogenous leukemia].
Aul C; Fischer JT; Schneider W
Onkologie; 1983 Dec; 6(6):280-6. PubMed ID: 6366672
[TBL] [Abstract][Full Text] [Related]
2. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.
Cheson BD; Cassileth PA; Head DR; Schiffer CA; Bennett JM; Bloomfield CD; Brunning R; Gale RP; Grever MR; Keating MJ
J Clin Oncol; 1990 May; 8(5):813-9. PubMed ID: 2185339
[TBL] [Abstract][Full Text] [Related]
3. Use of myeloperoxidase mRNA as a marker for myeloid lineage in acute leukemias.
Crisan D; David D; DiCarlo R
Arch Pathol Lab Med; 1996 Sep; 120(9):828-34. PubMed ID: 9140287
[TBL] [Abstract][Full Text] [Related]
4. Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT.
Canaani J; Beohou E; Labopin M; Socié G; Huynh A; Volin L; Cornelissen J; Milpied N; Gedde-Dahl T; Deconinck E; Fegueux N; Blaise D; Mohty M; Nagler A
Am J Hematol; 2017 Apr; 92(4):344-350. PubMed ID: 28052366
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties.
Terstappen LW; Könemann S; Safford M; Loken MR; Zurlutter K; Büchner T; Hiddemann W; Wörmann B
Leukemia; 1991 Apr; 5(4):315-21. PubMed ID: 2027298
[TBL] [Abstract][Full Text] [Related]
6. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.
Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
Ann Intern Med; 1985 Oct; 103(4):620-5. PubMed ID: 3862359
[No Abstract] [Full Text] [Related]
7. Cytochemical Staining.
Paessler ME; Helfrich M; Wertheim GBW
Methods Mol Biol; 2017; 1633():19-32. PubMed ID: 28735478
[TBL] [Abstract][Full Text] [Related]
8. The continuous-flow cytochemistry: its applications in the classification of acute myeloblastic and lymphoblastic leukemias.
Milanesi B
Quad Sclavo Diagn; 1982 Dec; 18(4):433-9. PubMed ID: 6964596
[No Abstract] [Full Text] [Related]
9. [Differential diagnostic criteria of blast cells in the peripheral blood in acute myeloid leukemias].
Gaĭdukova SN; Guseva SA; Tishchenko LM
Vrach Delo; 1989 Sep; (9):38-41. PubMed ID: 2558447
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
11. Simplified method for the discrimination of acute myelogenous and non-myelogenous leukemias.
Hirsch FW; Engelhardt R; Löhr GW
Blut; 1983 Aug; 47(2):115-6. PubMed ID: 6191804
[TBL] [Abstract][Full Text] [Related]
12. Classification of acute myeloid leukaemia in trephine biopsies with special reference to lactoferrin.
Al Safadi L; Köhler G; Schaefer HE
Anticancer Res; 1998; 18(5B):3677-84. PubMed ID: 9854476
[TBL] [Abstract][Full Text] [Related]
13. Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia.
Niemann CU; Kjeldsen L; Ralfkiaer E; Jensen MK; Borregaard N
Leukemia; 2007 Dec; 21(12):2406-10. PubMed ID: 17928883
[TBL] [Abstract][Full Text] [Related]
14. Reclassification of leukemia among A-bomb survivors in Nagasaki using French-American-British (FAB) classification for acute leukemia.
Matsuo T; Tomonaga M; Bennett JM; Kuriyama K; Imanaka F; Kuramoto A; Kamada N; Ichimaru M; Finch SC; Pisciotta AV
Jpn J Clin Oncol; 1988 Jun; 18(2):91-6. PubMed ID: 2898029
[TBL] [Abstract][Full Text] [Related]
15. Eyelid myeloid sarcoma: ominous presentation of acute myelogenous leukemia.
Phelps PO; Marcet MM; Hong AR; Nichols JW
Orbit; 2015 Feb; 34(1):30-2. PubMed ID: 25058666
[TBL] [Abstract][Full Text] [Related]
16. Acute myelogenous leukemia suddenly developing just after surgery for advanced gastric cancer: report of a case.
Ubukata H; Katano M; Takemura A; Kasuga T; Motohashi G; Ge L; Tabuchi T
Surg Today; 2005; 35(2):153-6. PubMed ID: 15674499
[TBL] [Abstract][Full Text] [Related]
17. [Morphocytochemical and immunological criteria for the diagnosis and prognosis of the course of acute myelogenous. leukemias].
Shakhbazian GP; Dul'tsina SM; Potapova SG; Abakumov EM; Isaev VG
Probl Gematol Pereliv Krovi; 1982 Nov; 27(11):17-22. PubMed ID: 6961396
[No Abstract] [Full Text] [Related]
18. [Diagnostics, classification and prognostic criteria of acute myeloid leukemia].
Heilmeier B; Buske C; Spiekermann K; Bohlander S; Feuring-Buske M; Hiddemann W; Braess J
Med Klin (Munich); 2007 Apr; 102(4):296-308. PubMed ID: 17426933
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases.
Zhang PJ; Barcos M; Stewart CC; Block AW; Sait S; Brooks JJ
Mod Pathol; 2000 Apr; 13(4):452-8. PubMed ID: 10786814
[TBL] [Abstract][Full Text] [Related]
20. p-Iodophenol-enhanced luminol chemiluminescent assay applied to discrimination between acute lymphoblastic and minimally differentiated acute myeloid (FAB-M0) or acute megakaryoblastic (FAB-M7) leukemias.
da Costa M; Ximenes VF; Brunetti IL; Falcão RP; da Fonseca LM
Hematol J; 2004; 5(6):496-9. PubMed ID: 15570291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
